Skip to main content
Equibles

Asset Dedication, LLC

Position in NNVC — Nanoviricides, Inc.

CIK 1475896 SAN FRANCISCO, CA
Back to NNVC Full portfolio

Position in NNVC

as of Jun 30, 2026 · filed Jul 30, 2026
Position Value
$2,001
+$682 QoQ
Shares Held
1,450
0.0% QoQ
Ownership
0.007%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#30
of 48 holders
Holding Since
Sep 2022
16 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in NNVC Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Asset Dedication, LLC holds $189,361 across 9 Biotechnology names. NNVC ranks #5 (1.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 237 $117,725
2 MRNA
Moderna, Inc.
 843 $59,035
3 BNTX
BioNTech SE
 37 $3,442
4 RPRX
Royalty Pharma plc
 49 $2,747
5 NNVC
Nanoviricides, Inc.
This page 		1,450 $2,001
6 ALNY
Alnylam Pharmaceuticals, Inc.
 6 $1,806
7 PRTA
Prothena Corp Public Ltd Co
 184 $1,801
8 NVAX
Novavax Inc
 65 $612

All Filings in NNVC

Export CSV
16 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,001 1,450
2026-03-31 $1,319 1,450
2025-12-31 $1,638 1,450
2025-09-30 $2,073 1,450
2025-06-30 $2,030 1,450
2025-03-31 $1,696 1,450
2024-12-31 $2,073 1,450
2024-09-30 $2,175 1,450
2024-06-30 $2,494 1,450
2024-03-31 $2 1,450
2023-12-31 $1 1,450
2023-09-30 $1,943 1,450
2023-06-30 $2 1,450
2023-03-31 $2 1,450
2022-12-31 $2 1,450
2022-09-30 $2,508 1,450